IVR-CT Devices (Imaging Rooms 17 and 18) for FY2024-25 Medical Equipment Investment

Open tender

Japanese title: 【令和6・7年度医療機器投資】IVR-CT装置(撮影室17・18) 二式

Medical
About this page
This page is based on the official tender notice and presents information processed, translated, and edited by JBid.

Overview

This tender is for the procurement of two IVR-CT devices for imaging rooms 17 and 18 as part of the FY2024-25 medical equipment investment at the National Cancer Center Central Hospital. Delivery is required by December 31, 2027. The contract will be awarded by comprehensive evaluation, and bidders must include all related expenses in their proposals.

Key Details

  • Source: Kanpo
  • Notice type: Open tender
  • Publication date: September 17, 2026
  • Procuring entity: Manno Hiroyuki, Director of the National Cancer Center
  • Deadline to obtain tender documents: November 6, 2026, 08:30 JST
  • Submission deadline: November 6, 2026, 17:00 JST
  • Bid opening: November 19, 2026, 14:00 JST, location: see the official notice
  • Award method: Comprehensive evaluation (price + technical score)
  • Eligibility (from notice): All-ministry unified qualification, 'goods manufacturing or goods sales', grade A–C, Kanto-Koshinetsu region – verify in the tender documents
  • Status: Active
  • Technology relevance: Possible
  • Business-action likelihood: Medium – The procurement is a specialized medical device purchase with a formal competitive tender process, but local after-sales service capability and regional qualification requirements may require partnership or local presence.

Official Notice

Official Source

Kanpo, Japan's official government gazette, in which legally required public procurement notices are formally published.

  • Source: Kanpo, Government Procurement Notice Edition
  • Official category: Tender notice
  • Publication date: September 17, 2026
  • Publication: Kanpo, pages 9

Full English Translation

The following English translation was prepared from the original Japanese notice published in Kanpo. Where an official English summary appears in the Kanpo publication, it was used only for verification; the translation below is based on the Japanese source text.

Tender Notice:
The following general competitive tender is announced. Date: September 17, 2026. National Cancer Center, Director Manno Hiroyuki. Procurement agency number 819. Location number 13. No. 25.
1 Procurement details:
(1) Item classification numbers 22, 31.
(2) Procurement subject and quantity: FY2024-25 Medical Equipment Investment: Two IVR-CT devices (Imaging Rooms 17 and 18).
(3) Characteristics of the procurement subject: As per the tender documents and specifications.
(4) Delivery period: From contract conclusion date until December 31, 2027.
(5) Delivery location: National Cancer Center Central Hospital.
(6) Tender method: The successful bidder will be decided by comprehensive evaluation.

1. Bidders must submit a bid including direct costs related to the procurement subject, as well as all expenses required for the contract such as equipment, materials, machinery, transportation, etc., estimating the contract amount.

2. For deciding the successful bidder, the bid amount plus 10% of that amount (fractions less than one yen are truncated) will be considered the application amount; bidders must submit a bid with the amount equivalent to 100/110 of the estimated contract amount regardless of tax status.

3. Submit materials necessary for comprehensive evaluation as described in the tender documents.
2 Qualifications required for participation:
(1) Persons disqualified under Articles 6 and 7 of the National Cancer Center Contract Handling Regulations cannot participate.
(2) Persons who have submitted false information or whose management or credit status has severely deteriorated may be excluded.
(3) Persons rated A, B, or C in manufacturing or sales of goods with competition qualifications in the Kanto-Koshinetsu region per the unified qualification notification.
(4) Persons who can prove a system for prompt after-sales service and maintenance for the purchased goods.
3 Contract terms and period:
(1) Locations for contract terms, tender document distribution, and bid submission: National Cancer Center Finance and Accounting Department (Tsukiji C), Procurement Section 1, Procurement Division, Misato Ishigami, Phone 03-3547-5201 ext. 3446.
(2) Tender document distribution period: From September 17, 2026 (Thu) to November 6, 2026 (Fri), 8:30-17:00.
(3) Bid submission deadline: November 6, 2026 (Fri) 17:00 (must arrive by then).
(4) Bid opening date and place: November 19, 2026 (Thu) 14:00, National Cancer Center Central Hospital Management Building 1F, Meeting Room 4.
4 Other matters:
(1) Language and currency for contract procedures: Japanese and Japanese yen.
(2) Invalid bids: Bids from ineligible participants or those who fail obligations will be invalid.
(3) Contract document creation: Required.
(4) Method of contractor selection: The bidder who meets all qualification and specification requirements, submits required documents, and whose bid is within the estimated price limit per Articles 37 and 38 of the Contract Handling Regulations, and has the highest evaluation score, will be awarded and enter contract negotiations.
(5) Other details per tender documents. Contact: National Cancer Center Finance and Accounting Department (Tsukiji C), Procurement Section 1, Misato Ishigami, Phone 03-3547-5201 ext. 3446.
Show original Japanese notice

入札公告

次のとおり一般競争入札に付します。令和8年9月17日国立研究開発法人国立がん研究センター理事長間野博行◎調達機関番号819 ◎所在地番号13〇第25号1 調達内容(1)品目分類番号　22、31(2)調達件名及び数量 【令和6・7年度医療機器投資】IVR-CT装置(撮影室17・18) 二式(3)調達件名の特質等　入札説明書及び仕様書による。(4)納入期間　契約締結日から令和9年12月31日まで。 (5) 履行場所　国立研究開発法人国立がん研究センター中央病院(6)入札方法　落札者の決定は、総合評価落札方式をもって行うので、 1入札者が提出する入札書は、調達件名にかかる直接経費の他、機材、資材、機械器具、運搬費等、業務委託に要する一切の諸経費を含め、契約金額を見積もるものとする。 2 落札者決定にあたっては、入札書に記載された金額に当該金額の10%に相当する額を加算した金額(当該金額に1円未満の端数がある場合は、その端数金額を切り捨てた金額とする。)をもって申込金額とするので、入札者は、消費税及び地方消費税に係る課税事業者であるか免税事業者であるかを問わず、見積もった契約金額の110分の100に相当する金額を記載した入札書を提出しなければならない。3 入札説明書等に記載されている総合評価に必要な資料を提出する。2 競争に参加する者に必要な資格に関する事項(1)国立研究開発法人国立がん研究センター契約事務取扱細則第6条及び7条に規定される各事項に該当される者は、競争に参加できない。(2)次の事項に該当する者は、競争に参加させないことがある。 1 資格審査申請書又は添付書類に虚偽の事実を記載した者2経営の状況又は信用度が極度に悪化している者(3)資格審査結果通知書(全省庁統一資格)において「物品の製造」又は「物品の販売」のうちA、B又はCの等級に格付けされ、関東・甲信越地域の競争資格を有する者。(4)購入物品にかかる迅速なアフターサービス・メンテナンスの体制が整備されていることを証明した者であること。3 契約条項を示す場所及び期間(1)契約条項を示す場所、入札説明書の交付場所、入札書の提出場所は、次のとおりとする。 〒104-0045　東京都中央区築地5-1-1国立研究開発法人国立がん研究センター財務経理部(築地C)調達課調達第一係石神美里　電話03-3547-5201(内線3446)(2)入札説明書等交付期間　令和8年9月17日 (木)から令和8年11月6日(金)8時30分から17時00分まで。(3)入札書受領期限令和8年11月6日(金) 17時00分(必着)(4)開札の日時及び場所　令和8年11月19日 (木)14時00分　国立がん研究センター中央病院管理棟1階第四会議室4 その他の事項(1)契約手続において使用する言語及び通貨　日本語及び日本国通貨とする。(2)入札の無効　本公告に示した競争参加資格のない者の提出した入札書、入札者に求められる義務を履行しなかった者の提出した入札書は無効とする。(3)契約書作成の要否　要(4)契約者の決定方法本公告及び入札説明書に従い、書類・資料を添付した入札書を提出した入札者であって、本入札公告及び入札説明書の競争参加資格及び仕様書の要求、要件を全て満たし、当該入札者の入札書が国立研究開発法人国立がん研究センター契約事務取扱細則第37条、及び38条の規定に基づいて作成された予定価格の制限の範囲内であり、かつ、最高評価点をもって入札を行った者を落札者とし、契約交渉の相手方とする。(5)その他詳細は入札説明書による。 【照会先】国立研究開発法人国立がん研究センター財務経理部(築地C)調達課調達第一係石神美里　電話03-3547-5201(内線3446)

Business Signal

Business Relevance

Potential relevance requires a targeted fit check. Confirm the supplier's documented capabilities against the actual requirements and verify a participation route.

  • Product fit: Potential
  • Current-case feasibility: Unknown
  • Evidence confidence: Low
  • Supply-chain security: Unknown

Earliest required deadline in the examined route (Japan time): 2026-11-06T17:00:00+09:00

Participation fit

Participation is expected to require appropriate Japanese government procurement eligibility, or cooperation with a suitable Japanese partner holding the required qualification. The eligibility requirements have not been fully reviewed and should be verified against the official tender documents.

This page is based on the official Kanpo tender notice, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.

JBid is a beta technology-procurement intelligence service by I.J. Do.

Back to daily list